These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26426296)

  • 1. A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme Assay.
    Kashem MA; Kennedy CA; Fogarty KE; Dimock JR; Zhang Y; Sanville-Ross ML; Skow DJ; Brunette SR; Swantek JL; Hummel HS; Swindle J; Nelson RM
    Assay Drug Dev Technol; 2016; 14(1):39-49. PubMed ID: 26426296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.
    Congdon MD; Childress ES; Patwardhan NN; Gumkowski J; Morris EA; Kharel Y; Lynch KR; Santos WL
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4956-4960. PubMed ID: 25862200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors.
    Kharel Y; Agah S; Huang T; Mendelson AJ; Eletu OT; Barkey-Bircann P; Gesualdi J; Smith JS; Santos WL; Lynch KR
    PLoS One; 2018; 13(4):e0192179. PubMed ID: 29672528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.
    Schnute ME; McReynolds MD; Carroll J; Chrencik J; Highkin MK; Iyanar K; Jerome G; Rains JW; Saabye M; Scholten JA; Yates M; Nagiec MM
    J Med Chem; 2017 Mar; 60(6):2562-2572. PubMed ID: 28231433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
    Lynch KR; Thorpe SB; Santos WL
    Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.
    Li H; Sibley CD; Kharel Y; Huang T; Brown AM; Wonilowicz LG; Bevan DR; Lynch KR; Santos WL
    Bioorg Med Chem; 2021 Jan; 30():115941. PubMed ID: 33385956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.
    Congdon M; Fritzemeier RG; Kharel Y; Brown AM; Serbulea V; Bevan DR; Lynch KR; Santos WL
    Eur J Med Chem; 2021 Feb; 212():113121. PubMed ID: 33445156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-binding cassette ABCC1 is involved in the release of sphingosine 1-phosphate from rat uterine leiomyoma ELT3 cells and late pregnant rat myometrium.
    Tanfin Z; Serrano-Sanchez M; Leiber D
    Cell Signal; 2011 Dec; 23(12):1997-2004. PubMed ID: 21803151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
    Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
    Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia.
    LeBlanc FR; Liu X; Hengst J; Fox T; Calvert V; Petricoin EF; Yun J; Feith DJ; Loughran TP
    Cancer Biol Ther; 2015; 16(12):1830-40. PubMed ID: 26252351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of Sphingosine Kinases Inhibitors: Challenges and Recent Developments.
    Magli E; Corvino A; Fiorino F; Frecentese F; Perissutti E; Saccone I; Santagada V; Caliendo G; Severino B
    Curr Pharm Des; 2019; 25(9):956-968. PubMed ID: 30947653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
    Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
    J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
    Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
    Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry.
    Highkin MK; Yates MP; Nemirovskiy OV; Lamarr WA; Munie GE; Rains JW; Masferrer JL; Nagiec MM
    J Biomol Screen; 2011 Feb; 16(2):272-7. PubMed ID: 21297110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells.
    Böhm A; Flößer A; Ermler S; Fender AC; Lüth A; Kleuser B; Schrör K; Rauch BH
    Cardiovasc Res; 2013 Aug; 99(3):505-13. PubMed ID: 23658376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a simple and robust assay to screen for inhibitors of sphingosine kinases.
    Togame H; Dodo R; Inaoka T; Reinemer P
    Assay Drug Dev Technol; 2007 Apr; 5(2):215-23. PubMed ID: 17477830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.